Skip to main content

Table 2 Overview of CMR findings

From: Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients

 

Total (N = 88)

DMD (N = 20)

BMD (N = 68)

p-value

LV-EDV index, ml/m2

80 (62–104)

54 (48–64)

85 (69–107)

<0.001

LV-ESV index, ml/m2

33 (24–56)

21 (14–30)

38 (27–62)

<0.001

LV mass index, mg/m2

58 ± 16

42 ± 14

63 ± 14

<0.001

LV-EF,%

53 ± 14

60 ± 11

51 ± 15

0.014

LV-EF <55%, n (%)

45 (51)

7 (35)

38 (56)

0.13

RV-EDV index, ml/m2

63 (51–78)

49 (40–59)

65 (58–81)

<0.001

RV-ESV index, ml/m2

30 (23–36)

24 (19–29)

31 (25–39)

0.003

RV-EF,%

53 ± 10

51 ± 9

53 ± 10

0.32

LGE presence, n (%)

56 (64)

13 (65)

43 (63)

1.00

LGE extent,%

16 ± 13 (n = 56)

13 ± 12 (n = 13)

17 ± 14 (n = 43)

0.37

Transmural LGE, n (%)

20 (23)

5 (25)

15 (22)

0.77

  1. DMD – Duchene muscular dystrophy; BMD – Becker muscular dystrophy; LV – left ventricle; RV – right ventricle; EDV – end diastolic volume; ESV – end systolic volume; EF – ejection fraction; LGE – late gadolinium enhancement. Bold numbers indicate significant p-values/parameters.